DV
Dividend Vision

CSCI — COSCIENS Biopharma Inc.

COSCIENS Biopharma Inc. (CSCI)

Its deepest 1-year drawdown was 76.8%.

COSCIENS Biopharma Inc. is a life science company that develops and commercializes active ingredients and pharmaceutical products across cosmeceutical, nutraceutical, and pharmaceutical markets, including oat and yeast beta glucans for health applications and Macrilen/Ghryvelin (macimorelin) for growth hormone deficiency diagnosis. The company does not currently distribute to shareholders. COSCIENS appeals primarily to investors seeking exposure to specialty pharmaceutical and biotech innovation rather than current income.

CSCI key facts

Asset type
Stock
Asset class
Equity
Inception date
05/10/2000
Last close
$7.88
Market cap
$8,641,549
Average volume
786.0
Beta
1.852
Payout ratio
0.0
Forward P/E
0.0
EPS
$-6.54